Page last updated: 2024-08-21

evans blue and Classic Globoid Cell Leukodystrophy

evans blue has been researched along with Classic Globoid Cell Leukodystrophy in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fantz, CR; Sands, MS; Young, PP	1

Other Studies

1 other study(ies) available for evans blue and Classic Globoid Cell Leukodystrophy

Article	Year
VEGF disrupts the neonatal blood-brain barrier and increases life span after non-ablative BMT in a murine model of congenital neurodegeneration caused by a lysosomal enzyme deficiency. Experimental neurology, 2004, Volume: 188, Issue:1 Topics: Animals; Animals, Newborn; Blood-Brain Barrier; Bone Marrow Transplantation; Cell Count; Disease Models, Animal; Evans Blue; Female; Genetic Therapy; Genetic Vectors; Graft Survival; Heredodegenerative Disorders, Nervous System; Humans; Injections, Intravenous; Leukodystrophy, Globoid Cell; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Survival Rate; Treatment Outcome; Up-Regulation; Vascular Endothelial Growth Factor A	2004

Article

Year

VEGF disrupts the neonatal blood-brain barrier and increases life span after non-ablative BMT in a murine model of congenital neurodegeneration caused by a lysosomal enzyme deficiency.

Experimental neurology, 2004, Volume: 188, Issue:1

Topics: Animals; Animals, Newborn; Blood-Brain Barrier; Bone Marrow Transplantation; Cell Count; Disease Models, Animal; Evans Blue; Female; Genetic Therapy; Genetic Vectors; Graft Survival; Heredodegenerative Disorders, Nervous System; Humans; Injections, Intravenous; Leukodystrophy, Globoid Cell; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Survival Rate; Treatment Outcome; Up-Regulation; Vascular Endothelial Growth Factor A

2004